The world’s first targeted vaccine against the Bovine Viral Diarrhea Virus (BVDV), developed by Bioinnovo, was one of 4 finalists in its category among around 1,000 projects submitted at the 13th edition of the Pioneering Solutions Contest from Banco Nación, aimed at SMEs and enterprises….
Knowledge about the impact of this virus on production and control measures to mitigate its effect on the herd was disseminated at the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), convened by Bioinnovo and INTA. The Second International BVDV Congress, held virtually by…
Organized by the American Society of Animal Science (ASAS), the 2021 ASAS-CSAS-SSASAS Annual Meeting & Trade Show will be held on July 14-17 in a hybrid modality. During the event, Bioinnovo representatives will present the studies conducted with Vedevax BLOCK, the first targeted subunit vaccine against…
RedBio Argentina awarded the poster of Bioinnovo on the latest field results of the first subunit vaccine against the bovine viral diarrhea virus, Vedevax BLOCK. During the 13th RedBio National Symposium 2021, held on June 8-11, with the title “Biotechnology as a Solution to Past Challenges,” technical posters were exhibited. Bioinnovo’s…